A polyamine metabolism risk signature for predicting the prognosis and immune therapeutic response of kidney cancer.

Bo Li, Zheng Kong,Yang Liu, Bifeng Xu,Xun Liu,Shuai Li,Zhihong Zhang

Translational cancer research（2023）

引用 0|浏览0

暂无评分

摘要

In summary, our study identified several potentially important PMRGs in KIRC and constructed a practical risk signature, which could serve as a foundation for further development of polyamine metabolism-based targeted therapies for KIRC.

查看译文

关键词

polyamine metabolism risk signature,kidney cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要